How to minimize peri-procedural complications during subcutaneous defibrillator implant?

References

• Al-Khatib SM, Friedman P, Ellenbogen KA. Defibrillators: selecting the right device for the right patient. Circulation. 2016;134:1390–1404.
   PubMed Web of Science ®Google Scholar
• Afzal MR, Okabe T, Koppert T, et al. Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia care. Pacing Clin Electrophysiol. 2019;42:1552–1557.
   PubMed Web of Science ®Google Scholar
• Okabe T, Miller A, Koppert T, et al. Feasibility and safety of same day subcutaneous defibrillator implantation and send home (DASH) strategy. J Interv Card Electrophysiol. 2020;57:311–318.
   PubMed Web of Science ®Google Scholar
• Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65:1605–1615.
   PubMed Web of Science ®Google Scholar
• Lambiase PD, Barr C, Theuns DA, et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J. 2014;35:1657–1665.
   PubMed Web of Science ®Google Scholar
• Weiss R, Knight BP, Gold MR, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–953.
   PubMed Web of Science ®Google Scholar
• El-Chami MF, Levy M, Kelli HM, et al. Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis. J Cardiovasc Electrophysiol. 2015;26:900–904.
   PubMed Web of Science ®Google Scholar
• Boersma LV, El-Chami MF, Bongiorni MG, et al. Understanding outcomes with the EMBLEM S-ICD in primary prevention patients with low EF study (UNTOUCHED): clinical characteristics and perioperative results. Heart Rhythm. 2019;16:1636–1644.
   PubMed Web of Science ®Google Scholar
• Brouwer TF, Knops RE, Kutyifa V, et al. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Europace. 2018;20:f240–f248.
   PubMed Web of Science ®Google Scholar
• Afzal MR, Ahmed A, Prutkin JM, et al. Multicenter experience of concomitant use of left ventricular assist devices and subcutaneous implantable cardioverter-defibrillators. JACC Clin Electrophysiol. 2018;4:1261–1262.
   PubMedGoogle Scholar
• Brouwer TF, Yilmaz D, Lindeboom R, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68:2047–2055.
   PubMed Web of Science ®Google Scholar
• Lambiase PD, Gold MR, Hood M, et al. Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. Heart Rhythm. 2016;13:1066–1074.
   PubMed Web of Science ®Google Scholar
• Brisben AJ, Burke MC, Knight BP, et al. A new algorithm to reduce inappropriate therapy in the S-ICD system. J Cardiovasc Electrophysiol. 2015;26:417–423.
   PubMed Web of Science ®Google Scholar
• Theuns D, Brouwer TF, Jones PW, et al. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2018;15:1515–1522.
   PubMed Web of Science ®Google Scholar
• Kaya E, Rassaf T, Wakili R. Subcutaneous ICD: current standards and future perspective. Int J Cardiol Heart Vasc. 2019;24:100409.
   PubMed Web of Science ®Google Scholar
• Bogeholz N, Pauls P, Guner F, et al. Direct comparison of the novel automated screening tool (AST) versus the manual screening tool (MST) in patients with already implanted subcutaneous ICD. Int J Cardiol. 2018;265:90–96.
   PubMed Web of Science ®Google Scholar
• Francia P, Ziacchi M, De Filippo P, et al. Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool. J Interv Card Electrophysiol. 2018;52:61–67.
   PubMed Web of Science ®Google Scholar
• Knops RE, Olde Nordkamp LR, de Groot JR, et al. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013;10:1240–1243.
   PubMed Web of Science ®Google Scholar
• Brouwer TF, Miller MA, Quast AB, et al. Implantation of the subcutaneous implantable cardioverter-defibrillator: an evaluation of 4 implantation techniques. Circ Arrhythm Electrophysiol. 2017;10:e004663.
   PubMed Web of Science ®Google Scholar
• Zeb M, Curzen N, Allavatam V, et al. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool. Int J Cardiol. 2015;195:205–209.
   PubMed Web of Science ®Google Scholar
• Afzal MR, Badin A, Weiss R, et al. T-wave oversensing from postural changes: a rare cause of inappropriate shock from a subcutaneous defibrillator. HeartRhythm Case Rep. 2017;3:380–383.
   PubMedGoogle Scholar
• Olde Nordkamp LR, Brouwer TF, Barr C, et al. Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. Int J Cardiol. 2015;195:126–133.
   PubMed Web of Science ®Google Scholar
• Ahmed AS, Patel PJ, Bagga S, et al. Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2018;29:477–481.
   PubMed Web of Science ®Google Scholar
• Frankel DS, Burke MC, Callans DJ, et al. Impact of body mass index on safety and efficacy of the subcutaneous implantable cardioverter-defibrillator. JACC Clin Electrophysiol. 2018;4:652–659.
   PubMedGoogle Scholar
• Amin AK, Gold MR, Burke MC, et al. Factors associated with high-voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success. Circ Arrhythm Electrophysiol. 2019;12:e006665.
   PubMed Web of Science ®Google Scholar
• de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2:29–34.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Wang J, Alings M, et al. Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol. 2019;74:2845–2854.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Longtin Y, Philippon F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol. 2018;72:3098–3109.
   PubMed Web of Science ®Google Scholar
• Essandoh MK, Otey AJ, Abdel-Rasoul M, et al. Monitored anesthesia care for subcutaneous cardioverter-defibrillator implantation: a single-center experience. J Cardiothorac Vasc Anesth. 2016;30:1228–1233.
   PubMed Web of Science ®Google Scholar
• Afzal MR, Mehta D, Evenson C, et al. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2018;15:520–523.
   PubMed Web of Science ®Google Scholar
• Evenson C, Saour B, Afzal MR, et al. Increased risk of hematoma with uninterrupted warfarin in patients undergoing implantation of subcutaneous implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2019;42:1111–1114.
   PubMed Web of Science ®Google Scholar
• Sheldon SH, Cunnane R, Lavu M, et al. Perioperative hematoma with subcutaneous ICD implantation: impact of anticoagulation and antiplatelet therapies. Pacing Clin Electrophysiol. 2018;41:799–806.
   PubMed Web of Science ®Google Scholar
• Droghetti A, Basso Ricci E, Scimia P, et al. Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation. Pacing Clin Electrophysiol. 2018;41:517–523.
   PubMed Web of Science ®Google Scholar
• Miller MA, Garg J, Salter B, et al. Feasibility of subcutaneous implantable cardioverter-defibrillator implantation with opioid sparing truncal plane blocks and deep sedation. J Cardiovasc Electrophysiol. 2019;30:141–148.
   PubMed Web of Science ®Google Scholar
• Migliore F, De Franceschi P, De Lazzari M, et al. Ultrasound-guided serratus anterior plane block for subcutaneous implantable cardioverter defibrillator implantation using the intermuscular two-incision technique. J Interv Card Electrophysiol. 2020;57:303–309.
   PubMed Web of Science ®Google Scholar
• Migliore F, Mattesi G, De Franceschi P, et al. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique. J Cardiovasc Electrophysiol. 2019;30:854–864.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Fauchier L, Stiles MK, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2016;18:159–183.
   PubMed Web of Science ®Google Scholar
• Friedman DJ, Parzynski CS, Heist EK, et al. Ventricular fibrillation conversion testing after implantation of a subcutaneous implantable cardioverter defibrillator: report from the national cardiovascular data registry. Circulation. 2018;137:2463–2477.
   PubMed Web of Science ®Google Scholar
• Peddareddy L, Merchant FM, Leon AR, et al. Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2018;41:996–1000.
   Web of Science ®Google Scholar
• Miller MA, Palaniswamy C, Dukkipati SR, et al. Subcutaneous implantable cardioverter-defibrillator implantation without defibrillation testing. J Am Coll Cardiol. 2017;69:3118–3119.
   PubMed Web of Science ®Google Scholar
• Quast ABE, Baalman SWE, Betts TR, et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized ComParative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019;214:167–174.
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LR, Knops RE, Bardy GH, et al. Rationale and design of the PRAETORIAN trial: a prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163:753–760.e2.
   PubMed Web of Science ®Google Scholar
• Quast ABE, Baalman SWE, Van der Stuijt W, et al. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients. J Cardiovasc Electrophysiol. 2019;30:2441–2447.
   PubMed Web of Science ®Google Scholar
• le Polain de Waroux JB, Ploux S, Mondoly P, et al. Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. Heart Rhythm. 2018;15:642–650.
   PubMed Web of Science ®Google Scholar
• Diemberger I, Migliore F, Ricciardi G, et al. Time to therapy delivery and effectiveness of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2019;16:1531–1537.
   PubMed Web of Science ®Google Scholar
• Gold MR, Weiss R, Theuns DA, et al. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1352–1358.
   PubMed Web of Science ®Google Scholar
• Theuns D, Bhagwandien RE, Szili-Torok T, et al. Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy. J Interv Card Electrophysiol. 2019 Sep;55(3):317–323.
   Web of Science ®Google Scholar
• Afzal MR, Evenson C, Badin A, et al. Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2017;14:1436–1439.
   PubMed Web of Science ®Google Scholar
• Kuschyk J, Stach K, Tulumen E, et al. Subcutaneous implantable cardioverter-defibrillator: first single-center experience with other cardiac implantable electronic devices. Heart Rhythm. 2015;12:2230–2238.
   PubMed Web of Science ®Google Scholar
• Ng JB, Chua K, Teo WS. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-when vascular options have run out. J Arrhythm. 2019;35:136–138.
   PubMed Web of Science ®Google Scholar
• Ito R, Kondo Y, Winter J, et al. Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis. J Arrhythm. 2019;35:311–313.
   PubMed Web of Science ®Google Scholar
• Tjong FVY, Brouwer TF, Koop B, et al. Acute and 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol. 2017;3:1487–1498.
   PubMedGoogle Scholar
• Tjong FVY, Koop BE. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD. Herzschrittmacherther Elektrophysiol. 2018;29:355–361.
   PubMedGoogle Scholar
• Varma N, Ricci RP. Telemedicine and cardiac implants: what is the benefit? Eur Heart J. 2013;34:1885–1895.
   PubMed Web of Science ®Google Scholar
• De Filippo P, Luzi M, D’Onofrio A, et al. Remote monitoring of subcutaneous implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2018;53:373–381.
   PubMed Web of Science ®Google Scholar
• Boersma LV, Barr CS, Burke MC, et al. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. Heart Rhythm. 2017;14:367–375.
   PubMed Web of Science ®Google Scholar
• Essandoh MK, Mark GE, Aasbo JD, et al. Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: perspectives from the clinical experience of a U.S. panel of physicians. Pacing Clin Electrophysiol. 2018;41:807–816.
   PubMed Web of Science ®Google Scholar
• Miller MA, Bhatt HV, Weiner M, et al. Implantation of the subcutaneous implantable cardioverter-defibrillator with truncal plane blocks. Heart Rhythm. 2018;15:1108–1111.
   PubMed Web of Science ®Google Scholar